Effect of medroxyprogesterone acetate in the prevention of premature LH surge in IVF cycles

Not Applicable

Recruiting

• Conditions: infertility.; Female infertility, unspecified; N97.9

• Registration Number: IRCT20191205045621N2
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

age under 42 years
regular menstrual cycles over the previous 3-month period
antral follicle count (AFC) of 7-24 on menstrual cycle day 2–3
Normal TSH and Prolactin levels

Exclusion Criteria

endometriosis grade 3 or higher
diagnosis of polycystic ovarian syndrome
presence of ovarian cyst
hormone treatment receipt within the previous 3-month period
low ovarian reserve (AMH<1.1 or AFC<7)
any contraindication to ovarian stimulation treatment
basal serum FSH concentration of more than 10 IU/L

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of oocytes retrieved. Timepoint: on day of oocyte retrieval. Method of measurement: count.

Secondary Outcome Measures

Name	Time	Method
umber of mature oocytes. Timepoint: on day of oocyte retrieval. Method of measurement: count.;Clinical pregnancy. Timepoint: 3 weeks after IVF. Method of measurement: Measurement of beta-hCG.;Embryos number. Timepoint: after 24 hours and day 5. Method of measurement: microscopic evaluation.;Fertilization rate. Timepoint: 24 hours after intra-cytoplasmic sperm injection. Method of measurement: microscope.;Implantation rate. Timepoint: 2 weeks after embryo transfer. Method of measurement: Measurement of beta-hCG.